Outback Quit Pack: Feasibility trial of outreach smoking cessation for people in rural, regional, and remote Australia.
pharmacotherapy
randomised controlled trial
rural health
smoking cessation
telephone hotline
Journal
Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals
ISSN: 1036-1073
Titre abrégé: Health Promot J Austr
Pays: Australia
ID NLM: 9710936
Informations de publication
Date de publication:
15 Nov 2023
15 Nov 2023
Historique:
revised:
26
10
2023
received:
09
03
2023
accepted:
31
10
2023
medline:
16
11
2023
pubmed:
16
11
2023
entrez:
16
11
2023
Statut:
aheadofprint
Résumé
Tobacco smoking rates are higher in rural, regional, and remote (RRR) areas in Australia, and strategies to improve access to quit supports are required. This pilot study examined the feasibility of a smoking cessation intervention for people in RRR areas who smoke with the intention of using this data to design a powered effectiveness trial. A randomised controlled trial (RCT) of the feasibility of a 12-week 'Outback Quit Pack' intervention consisting of mailout combination nicotine replacement therapy (NRT) and a proactive referral to Quitline, compared with a minimal support control (1-page smoking cessation support information mailout) was conducted between January and October 2021. Participants recruited via mailed invitation or Facebook advertising, were adults who smoked tobacco (≥10 cigarettes/day) and resided in RRR areas of New South Wales, Australia. Participants completed baseline and 12-week follow-up telephone surveys. Outcomes were feasibility of trial procedures (recruitment method; retention; biochemical verification) and acceptability of intervention (engagement with Quitline; uptake and use of NRT). Facebook advertising accounted for 97% of participant expressions of interest in the study (N = 100). Retention was similarly high among intervention (39/51) and control (36/49) participants. The intervention was highly acceptable: 80% of the intervention group had ≥1 completed call with Quitline, whilst Quitline made 3.7 outbound calls/participant (mean 14:05 mins duration). Most of the intervention group requested NRT refills (78%). No differences between groups in self-reported cessation outcomes. Biochemical verification using expired air breath testing was not feasible in this study. The Outback Quit Pack intervention was feasible and acceptable. Alternative methods for remote biochemical verification need further study. SO WHAT?: A powered RCT to test the effectiveness of the intervention to improve access to evidence-based smoking cessation support to people residing in RRR areas is warranted.
Sections du résumé
BACKGROUND
BACKGROUND
Tobacco smoking rates are higher in rural, regional, and remote (RRR) areas in Australia, and strategies to improve access to quit supports are required. This pilot study examined the feasibility of a smoking cessation intervention for people in RRR areas who smoke with the intention of using this data to design a powered effectiveness trial.
METHODS
METHODS
A randomised controlled trial (RCT) of the feasibility of a 12-week 'Outback Quit Pack' intervention consisting of mailout combination nicotine replacement therapy (NRT) and a proactive referral to Quitline, compared with a minimal support control (1-page smoking cessation support information mailout) was conducted between January and October 2021. Participants recruited via mailed invitation or Facebook advertising, were adults who smoked tobacco (≥10 cigarettes/day) and resided in RRR areas of New South Wales, Australia. Participants completed baseline and 12-week follow-up telephone surveys. Outcomes were feasibility of trial procedures (recruitment method; retention; biochemical verification) and acceptability of intervention (engagement with Quitline; uptake and use of NRT).
RESULTS
RESULTS
Facebook advertising accounted for 97% of participant expressions of interest in the study (N = 100). Retention was similarly high among intervention (39/51) and control (36/49) participants. The intervention was highly acceptable: 80% of the intervention group had ≥1 completed call with Quitline, whilst Quitline made 3.7 outbound calls/participant (mean 14:05 mins duration). Most of the intervention group requested NRT refills (78%). No differences between groups in self-reported cessation outcomes. Biochemical verification using expired air breath testing was not feasible in this study.
CONCLUSION
CONCLUSIONS
The Outback Quit Pack intervention was feasible and acceptable. Alternative methods for remote biochemical verification need further study. SO WHAT?: A powered RCT to test the effectiveness of the intervention to improve access to evidence-based smoking cessation support to people residing in RRR areas is warranted.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Hunter Cancer Research Alliance
Organisme : Hunter Medical Research Institute
Organisme : NHMRC
ID : 1159601
Informations de copyright
© 2023 The Authors. Health Promotion Journal of Australia published by John Wiley & Sons Australia, Ltd on behalf of Australian Health Promotion Association.
Références
Australian Institute of Health and Welfare. National Drug Strategy Household Survey 2019. Canberra: AIHW; 2020.
Passey M, Fanaian M, Lyle D, Harris MF. Assessment and management of lifestyle risk factors in rural and urban general practices in Australia. Aust J Prim Health. 2010;16:81-86.
Tall J, Brew BK, Saurman E, Jones TC. Implementing an anti-smoking program in rural-remote communities: challenges and strategies. Rural Remote Health. 2015;15:140-154.
Zwar N, Richmond R, Borland R, Peters J, Litt J, Bell B. Supporting smoking cessation: a guide for health professionals. Melbourne: The Royal Australian College of General Practitioners; 2011.
Grunseit AC, Ding D, Anderson C, Crosbie D, Dunlop S, Bauman A. A profile of callers to the New South Wales Quitline, Australia, 2008-2011. Nicotine Tob Res. 2014;17:617-621. https://doi.org/10.1093/ntr/ntu198
Cummins SE, Bailey L, Campbell S, Koon-Kirby C, Zhu SH. Tobacco cessation quitlines in North America: a descriptive study. Tob Control. 2007;16(Suppl 1):i9-i15. https://doi.org/10.1136/tc.2007.020370
Kaufman A, Augustson E, Davis K, Finney Rutten LJ. Awareness and use of tobacco quitlines: evidence from the health information National Trends Survey. J Health Commun. 2010;15(Suppl 3):264-278. https://doi.org/10.1080/10810730.2010.526172
Wilson N, Weerasekera D, Borland R, Edwards R, Bullen C, Li J. Use of a national quitline and variation in use by smoker characteristics: ITC project New Zealand. Nicotine Tob Res. 2010;12(Suppl):S78-S84. https://doi.org/10.1093/ntr/ntq111
Dono J, Martin K, Bowden J, Miller C. A population-level analysis of changes in Australian smokers' preferences for smoking cessation support over two decades - from 1998 to 2017. Lancet Reg Health West Pac. 2022;19:100342. https://doi.org/10.1016/j.lanwpc.2021.100342
Khan A, Green K, Khandaker G, Lawler S, Gartner C. The impact of a regional smoking cessation program on referrals and use of Quitline services in Queensland, Australia: a controlled interrupted time series analysis. Lancet Reg Health West Pac. 2021;14:100210.
Vance L, Glanville B, Ramkumar K, Chambers J, Tzelepis F. The effectiveness of smoking cessation interventions in rural and remote populations: systematic review and meta-analyses. Int J Drug Policy. 2022;106:103775.
Byaruhanga J, Tzelepis F, Paul C, Wiggers J, Byrnes E, Lecathelinais C. Cost per participant recruited from rural and remote areas into a smoking cessation trial via online or traditional strategies: observational study. J Med Internet Res. 2019;21:e14911.
Abroms LC, Boal AL, Simmens SJ, Mendel JA, Windsor RA. A randomized trial of Text2Quit: a text messaging program for smoking cessation. Am J Prev Med. 2014;47:242-250. https://doi.org/10.1016/j.amepre.2014.04.010
Brown J, Michie S, Geraghty AWA, Yardley L, Gardner B, Shahab L, et al. Internet-based intervention for smoking cessation (StopAdvisor) in people with low and high socioeconomic status: a randomised controlled trial. Lancet Respir Med. 2014;2:997-1006. https://doi.org/10.1016/S2213-2600(14)70195-X
Herbec A, Brown J, Shahab L, West R. Lessons learned from unsuccessful use of personal carbon monoxide monitors to remotely assess abstinence in a pragmatic trial of a smartphone stop smoking app - a secondary analysis. Addict Behav Rep. 2019;9:100122. https://doi.org/10.1016/j.abrep.2018.07.003
Australian Bureau of Statistics. Remoteness structure. 2023 [cited 2023 Oct 12]. Available from: https://www.abs.gov.au/statistics/standards/australian-statistical-geography-standard-asgs-edition-3/jul2021-jun2026/remoteness-structure
Australian Centre for Housing Research. Accessibility/Remoteness Index of Australia (ARIA+). 2023 [cited 2023 Oct 12]. Available from: https://able.adelaide.edu.au/housing-research/data-gateway/aria
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377-381. https://doi.org/10.1016/j.jbi.2008.08.010
Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989;84:791-800.
Browne RH. On the use of a pilot sample for sample size determination. Stat Med. 1995;14:1933-1940.
Bonevski B, Randell M, Paul C, Chapman K, Twyman L, Bryant J, et al. Reaching the hard-to-reach: a systematic review of strategies for improving health and medical research with socially disadvantaged groups. BMC Med Res Methodol. 2014;14:42. https://doi.org/10.1186/1471-2288-14-42
Dahne J, Tomko RL, McClure EA, Obeid JS, Carpenter MJ. Remote methods for conducting tobacco-focused clinical trials. Nicotine Tob Res. 2020;22:2134-2140. https://doi.org/10.1093/ntr/ntaa105
Dono J, Martin K, Bowden J, Miller C. A population-level analysis of changes in Australian smokers' preferences for smoking cessation support over two decades-from 1998 to 2017. Lancet Reg Health West Pac. 2022;19:100342.
An LC, Schillo BA, Kavanaugh AM, Lachter RB, Luxenberg MG, Wendling AH, et al. Increased reach and effectiveness of a statewide tobacco quitline after the addition of access to free nicotine replacement therapy. Tob Control. 2006;15:286-293.
Bush TM, McAfee T, Deprey M, Mahoney L, Fellows J, McClure J, et al. The impact of a free nicotine patch starter kit on quit rates in a state quit line. Nicotine Tob Res. 2008;10:1511-1561. https://doi.org/10.1080/14622200802323167
Hollis JF, McAfee TA, Fellows JL, Zbikowski SM, Stark M, Riedlinger K. The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline. Tob Control. 2007;16:i53-i59.
Miller CL, Sedivy V. Using a quitline plus low-cost nicotine replacement therapy to help disadvantaged smokers to quit. Tob Control. 2009;18:144-149. https://doi.org/10.1136/tc.2008.026492
Pettigrew S, Jun M, Roberts I, Bullen C, Nallaiah K, Rodgers A. Preferences for tobacco cessation information and support during Covid-19. J Addict Med. 2020;14:e362-e365.
Lawrance K-A, Kirkwood A, Travis H, Selby P. Free, easy and effective: how young adults used 8 weeks of mailed nicotine patches and to what effect. J Smok Cess. 2020;15:206-213.